Global Recombinant Mouse Oncostatin M (OSM) Market Growth 2026-2032
The global Recombinant Mouse Oncostatin M (OSM) market size is predicted to grow from US$ 117 million in 2025 to US$ 196 million in 2032; it is expected to grow at a CAGR of 7.8% from 2026 to 2032.
Recombinant mouse oncostatin M (OSM) is a cytokine belonging to the interleukin-6 (IL-6) family, expressed by mouse T cells or monocytes, and has multiple biological functions. It plays a key role in cell proliferation, differentiation, inflammatory response, immune regulation and tumor suppression. Recombinant mouse OSM is often used in cell signaling pathway research, inflammatory model establishment, tumor microenvironment research and drug target verification, especially in the analysis of STAT3 pathway activation and acute inflammatory response mechanism. The protein is usually provided in a high-purity recombinant form and is suitable for mouse cell line or animal experiments.
With the deepening of research on inflammatory diseases, tumor immunity, regenerative medicine, etc., the market demand for recombinant OSM has gradually increased. At present, the price of scientific research-grade recombinant mouse OSM varies depending on purity and labeling. Common specifications such as 10?g or 100?g of freeze-dried protein cost between US$200 and US$800 (depending on the supplier). Judging from market trends, the potential of IL-6 family factors (such as OSM) in cytokine network regulation and immunotherapy has received increasing attention. It is expected that the market for this type of cytokines will grow steadily in the next few years, especially in the fields of biopharmaceuticals and immunology research in Europe, the United States and Asia.
United States market for Recombinant Mouse Oncostatin M (OSM) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Recombinant Mouse Oncostatin M (OSM) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Recombinant Mouse Oncostatin M (OSM) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Recombinant Mouse Oncostatin M (OSM) players cover Thermo Fisher Scientific Inc., Bio-Techne, Scientists Helping Scientists, Abcam Limited, FUJIFILM Irvine Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
This Insight Report provides a comprehensive analysis of the global Recombinant Mouse Oncostatin M (OSM) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Mouse Oncostatin M (OSM) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Mouse Oncostatin M (OSM) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Mouse Oncostatin M (OSM) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Mouse Oncostatin M (OSM).
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Mouse Oncostatin M (OSM) market by product type, application, key manufacturers and key regions and countries.
Recombinant mouse oncostatin M (OSM) is a cytokine belonging to the interleukin-6 (IL-6) family, expressed by mouse T cells or monocytes, and has multiple biological functions. It plays a key role in cell proliferation, differentiation, inflammatory response, immune regulation and tumor suppression. Recombinant mouse OSM is often used in cell signaling pathway research, inflammatory model establishment, tumor microenvironment research and drug target verification, especially in the analysis of STAT3 pathway activation and acute inflammatory response mechanism. The protein is usually provided in a high-purity recombinant form and is suitable for mouse cell line or animal experiments.
With the deepening of research on inflammatory diseases, tumor immunity, regenerative medicine, etc., the market demand for recombinant OSM has gradually increased. At present, the price of scientific research-grade recombinant mouse OSM varies depending on purity and labeling. Common specifications such as 10?g or 100?g of freeze-dried protein cost between US$200 and US$800 (depending on the supplier). Judging from market trends, the potential of IL-6 family factors (such as OSM) in cytokine network regulation and immunotherapy has received increasing attention. It is expected that the market for this type of cytokines will grow steadily in the next few years, especially in the fields of biopharmaceuticals and immunology research in Europe, the United States and Asia.
United States market for Recombinant Mouse Oncostatin M (OSM) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Recombinant Mouse Oncostatin M (OSM) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Recombinant Mouse Oncostatin M (OSM) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Recombinant Mouse Oncostatin M (OSM) players cover Thermo Fisher Scientific Inc., Bio-Techne, Scientists Helping Scientists, Abcam Limited, FUJIFILM Irvine Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Recombinant Mouse Oncostatin M (OSM) Industry Forecast” looks at past sales and reviews total world Recombinant Mouse Oncostatin M (OSM) sales in 2025, providing a comprehensive analysis by region and market sector of projected Recombinant Mouse Oncostatin M (OSM) sales for 2026 through 2032. With Recombinant Mouse Oncostatin M (OSM) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Mouse Oncostatin M (OSM) industry.This Insight Report provides a comprehensive analysis of the global Recombinant Mouse Oncostatin M (OSM) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Mouse Oncostatin M (OSM) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Mouse Oncostatin M (OSM) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Mouse Oncostatin M (OSM) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Mouse Oncostatin M (OSM).
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Mouse Oncostatin M (OSM) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- Purity?95%
- Purity ?95%
Segmentation by Application:
- University
- Research Center
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Thermo Fisher Scientific Inc.
- Bio-Techne
- Scientists Helping Scientists
- Abcam Limited
- FUJIFILM Irvine Scientific
- BD Biosciences
- Bio-Rad Laboratories, Inc.
- BPS Bioscience, Inc.
- Elabscience
- Yisheng Biotechnology (Shanghai) Co., Ltd.
- ENZO
- Beijing Biocreative Technology Co., Ltd.
- Shanghai Yaji Biotechnology Co., Ltd.
- Cellverse Co., Ltd.
- Dalian Meilun Biotech Co., Ltd.
- Sino Biological,Inc.
- Prospec-Tany Technogene Ltd
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Recombinant Mouse Oncostatin M (OSM) market?
- What factors are driving Recombinant Mouse Oncostatin M (OSM) market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Recombinant Mouse Oncostatin M (OSM) market opportunities vary by end market size?
- How does Recombinant Mouse Oncostatin M (OSM) break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant Mouse Oncostatin M (OSM) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Recombinant Mouse Oncostatin M (OSM) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Recombinant Mouse Oncostatin M (OSM) by Country/Region, 2021, 2025 & 2032
2.2 Recombinant Mouse Oncostatin M (OSM) Segment by Type
2.2.1 Purity?95%
2.2.2 Purity ?95%
2.2.3 Recombinant Mouse Oncostatin M (OSM) Sales by Type
2.2.3.1 Global Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Type (2021-2026)
2.2.3.2 Global Recombinant Mouse Oncostatin M (OSM) Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Recombinant Mouse Oncostatin M (OSM) Sale Price by Type (2021-2026)
2.3 Recombinant Mouse Oncostatin M (OSM) Segment by Application
2.3.1 University
2.3.2 Research Center
2.3.3 Recombinant Mouse Oncostatin M (OSM) Sales by Application
2.3.3.1 Global Recombinant Mouse Oncostatin M (OSM) Sale Market Share by Application (2021-2026)
2.3.3.2 Global Recombinant Mouse Oncostatin M (OSM) Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Recombinant Mouse Oncostatin M (OSM) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Recombinant Mouse Oncostatin M (OSM) Breakdown Data by Company
3.1.1 Global Recombinant Mouse Oncostatin M (OSM) Annual Sales by Company (2021-2026)
3.1.2 Global Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Company (2021-2026)
3.2 Global Recombinant Mouse Oncostatin M (OSM) Annual Revenue by Company (2021-2026)
3.2.1 Global Recombinant Mouse Oncostatin M (OSM) Revenue by Company (2021-2026)
3.2.2 Global Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Company (2021-2026)
3.3 Global Recombinant Mouse Oncostatin M (OSM) Sale Price by Company
3.4 Key Manufacturers Recombinant Mouse Oncostatin M (OSM) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Mouse Oncostatin M (OSM) Product Location Distribution
3.4.2 Players Recombinant Mouse Oncostatin M (OSM) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RECOMBINANT MOUSE ONCOSTATIN M (OSM) BY GEOGRAPHIC REGION
4.1 World Historic Recombinant Mouse Oncostatin M (OSM) Market Size by Geographic Region (2021-2026)
4.1.1 Global Recombinant Mouse Oncostatin M (OSM) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Recombinant Mouse Oncostatin M (OSM) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Recombinant Mouse Oncostatin M (OSM) Market Size by Country/Region (2021-2026)
4.2.1 Global Recombinant Mouse Oncostatin M (OSM) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Recombinant Mouse Oncostatin M (OSM) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Recombinant Mouse Oncostatin M (OSM) Sales Growth
4.4 APAC Recombinant Mouse Oncostatin M (OSM) Sales Growth
4.5 Europe Recombinant Mouse Oncostatin M (OSM) Sales Growth
4.6 Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Sales Growth
5 AMERICAS
5.1 Americas Recombinant Mouse Oncostatin M (OSM) Sales by Country
5.1.1 Americas Recombinant Mouse Oncostatin M (OSM) Sales by Country (2021-2026)
5.1.2 Americas Recombinant Mouse Oncostatin M (OSM) Revenue by Country (2021-2026)
5.2 Americas Recombinant Mouse Oncostatin M (OSM) Sales by Type (2021-2026)
5.3 Americas Recombinant Mouse Oncostatin M (OSM) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Mouse Oncostatin M (OSM) Sales by Region
6.1.1 APAC Recombinant Mouse Oncostatin M (OSM) Sales by Region (2021-2026)
6.1.2 APAC Recombinant Mouse Oncostatin M (OSM) Revenue by Region (2021-2026)
6.2 APAC Recombinant Mouse Oncostatin M (OSM) Sales by Type (2021-2026)
6.3 APAC Recombinant Mouse Oncostatin M (OSM) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Recombinant Mouse Oncostatin M (OSM) by Country
7.1.1 Europe Recombinant Mouse Oncostatin M (OSM) Sales by Country (2021-2026)
7.1.2 Europe Recombinant Mouse Oncostatin M (OSM) Revenue by Country (2021-2026)
7.2 Europe Recombinant Mouse Oncostatin M (OSM) Sales by Type (2021-2026)
7.3 Europe Recombinant Mouse Oncostatin M (OSM) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant Mouse Oncostatin M (OSM) by Country
8.1.1 Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Revenue by Country (2021-2026)
8.2 Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Sales by Type (2021-2026)
8.3 Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Mouse Oncostatin M (OSM)
10.3 Manufacturing Process Analysis of Recombinant Mouse Oncostatin M (OSM)
10.4 Industry Chain Structure of Recombinant Mouse Oncostatin M (OSM)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant Mouse Oncostatin M (OSM) Distributors
11.3 Recombinant Mouse Oncostatin M (OSM) Customer
12 WORLD FORECAST REVIEW FOR RECOMBINANT MOUSE ONCOSTATIN M (OSM) BY GEOGRAPHIC REGION
12.1 Global Recombinant Mouse Oncostatin M (OSM) Market Size Forecast by Region
12.1.1 Global Recombinant Mouse Oncostatin M (OSM) Forecast by Region (2027-2032)
12.1.2 Global Recombinant Mouse Oncostatin M (OSM) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Recombinant Mouse Oncostatin M (OSM) Forecast by Type (2027-2032)
12.7 Global Recombinant Mouse Oncostatin M (OSM) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Thermo Fisher Scientific Inc.
13.1.1 Thermo Fisher Scientific Inc. Company Information
13.1.2 Thermo Fisher Scientific Inc. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.1.3 Thermo Fisher Scientific Inc. Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Thermo Fisher Scientific Inc. Main Business Overview
13.1.5 Thermo Fisher Scientific Inc. Latest Developments
13.2 Bio-Techne
13.2.1 Bio-Techne Company Information
13.2.2 Bio-Techne Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.2.3 Bio-Techne Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Bio-Techne Main Business Overview
13.2.5 Bio-Techne Latest Developments
13.3 Scientists Helping Scientists
13.3.1 Scientists Helping Scientists Company Information
13.3.2 Scientists Helping Scientists Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.3.3 Scientists Helping Scientists Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Scientists Helping Scientists Main Business Overview
13.3.5 Scientists Helping Scientists Latest Developments
13.4 Abcam Limited
13.4.1 Abcam Limited Company Information
13.4.2 Abcam Limited Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.4.3 Abcam Limited Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Abcam Limited Main Business Overview
13.4.5 Abcam Limited Latest Developments
13.5 FUJIFILM Irvine Scientific
13.5.1 FUJIFILM Irvine Scientific Company Information
13.5.2 FUJIFILM Irvine Scientific Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.5.3 FUJIFILM Irvine Scientific Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 FUJIFILM Irvine Scientific Main Business Overview
13.5.5 FUJIFILM Irvine Scientific Latest Developments
13.6 BD Biosciences
13.6.1 BD Biosciences Company Information
13.6.2 BD Biosciences Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.6.3 BD Biosciences Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 BD Biosciences Main Business Overview
13.6.5 BD Biosciences Latest Developments
13.7 Bio-Rad Laboratories, Inc.
13.7.1 Bio-Rad Laboratories, Inc. Company Information
13.7.2 Bio-Rad Laboratories, Inc. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.7.3 Bio-Rad Laboratories, Inc. Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Bio-Rad Laboratories, Inc. Main Business Overview
13.7.5 Bio-Rad Laboratories, Inc. Latest Developments
13.8 BPS Bioscience, Inc.
13.8.1 BPS Bioscience, Inc. Company Information
13.8.2 BPS Bioscience, Inc. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.8.3 BPS Bioscience, Inc. Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 BPS Bioscience, Inc. Main Business Overview
13.8.5 BPS Bioscience, Inc. Latest Developments
13.9 Elabscience
13.9.1 Elabscience Company Information
13.9.2 Elabscience Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.9.3 Elabscience Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Elabscience Main Business Overview
13.9.5 Elabscience Latest Developments
13.10 Yisheng Biotechnology (Shanghai) Co., Ltd.
13.10.1 Yisheng Biotechnology (Shanghai) Co., Ltd. Company Information
13.10.2 Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.10.3 Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Yisheng Biotechnology (Shanghai) Co., Ltd. Main Business Overview
13.10.5 Yisheng Biotechnology (Shanghai) Co., Ltd. Latest Developments
13.11 ENZO
13.11.1 ENZO Company Information
13.11.2 ENZO Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.11.3 ENZO Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 ENZO Main Business Overview
13.11.5 ENZO Latest Developments
13.12 Beijing Biocreative Technology Co., Ltd.
13.12.1 Beijing Biocreative Technology Co., Ltd. Company Information
13.12.2 Beijing Biocreative Technology Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.12.3 Beijing Biocreative Technology Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Beijing Biocreative Technology Co., Ltd. Main Business Overview
13.12.5 Beijing Biocreative Technology Co., Ltd. Latest Developments
13.13 Shanghai Yaji Biotechnology Co., Ltd.
13.13.1 Shanghai Yaji Biotechnology Co., Ltd. Company Information
13.13.2 Shanghai Yaji Biotechnology Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.13.3 Shanghai Yaji Biotechnology Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Shanghai Yaji Biotechnology Co., Ltd. Main Business Overview
13.13.5 Shanghai Yaji Biotechnology Co., Ltd. Latest Developments
13.14 Cellverse Co., Ltd.
13.14.1 Cellverse Co., Ltd. Company Information
13.14.2 Cellverse Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.14.3 Cellverse Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Cellverse Co., Ltd. Main Business Overview
13.14.5 Cellverse Co., Ltd. Latest Developments
13.15 Dalian Meilun Biotech Co., Ltd.
13.15.1 Dalian Meilun Biotech Co., Ltd. Company Information
13.15.2 Dalian Meilun Biotech Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.15.3 Dalian Meilun Biotech Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Dalian Meilun Biotech Co., Ltd. Main Business Overview
13.15.5 Dalian Meilun Biotech Co., Ltd. Latest Developments
13.16 Sino Biological,Inc.
13.16.1 Sino Biological,Inc. Company Information
13.16.2 Sino Biological,Inc. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.16.3 Sino Biological,Inc. Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Sino Biological,Inc. Main Business Overview
13.16.5 Sino Biological,Inc. Latest Developments
13.17 Prospec-Tany Technogene Ltd
13.17.1 Prospec-Tany Technogene Ltd Company Information
13.17.2 Prospec-Tany Technogene Ltd Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.17.3 Prospec-Tany Technogene Ltd Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Prospec-Tany Technogene Ltd Main Business Overview
13.17.5 Prospec-Tany Technogene Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant Mouse Oncostatin M (OSM) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Recombinant Mouse Oncostatin M (OSM) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Recombinant Mouse Oncostatin M (OSM) by Country/Region, 2021, 2025 & 2032
2.2 Recombinant Mouse Oncostatin M (OSM) Segment by Type
2.2.1 Purity?95%
2.2.2 Purity ?95%
2.2.3 Recombinant Mouse Oncostatin M (OSM) Sales by Type
2.2.3.1 Global Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Type (2021-2026)
2.2.3.2 Global Recombinant Mouse Oncostatin M (OSM) Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Recombinant Mouse Oncostatin M (OSM) Sale Price by Type (2021-2026)
2.3 Recombinant Mouse Oncostatin M (OSM) Segment by Application
2.3.1 University
2.3.2 Research Center
2.3.3 Recombinant Mouse Oncostatin M (OSM) Sales by Application
2.3.3.1 Global Recombinant Mouse Oncostatin M (OSM) Sale Market Share by Application (2021-2026)
2.3.3.2 Global Recombinant Mouse Oncostatin M (OSM) Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Recombinant Mouse Oncostatin M (OSM) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Recombinant Mouse Oncostatin M (OSM) Breakdown Data by Company
3.1.1 Global Recombinant Mouse Oncostatin M (OSM) Annual Sales by Company (2021-2026)
3.1.2 Global Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Company (2021-2026)
3.2 Global Recombinant Mouse Oncostatin M (OSM) Annual Revenue by Company (2021-2026)
3.2.1 Global Recombinant Mouse Oncostatin M (OSM) Revenue by Company (2021-2026)
3.2.2 Global Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Company (2021-2026)
3.3 Global Recombinant Mouse Oncostatin M (OSM) Sale Price by Company
3.4 Key Manufacturers Recombinant Mouse Oncostatin M (OSM) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Mouse Oncostatin M (OSM) Product Location Distribution
3.4.2 Players Recombinant Mouse Oncostatin M (OSM) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RECOMBINANT MOUSE ONCOSTATIN M (OSM) BY GEOGRAPHIC REGION
4.1 World Historic Recombinant Mouse Oncostatin M (OSM) Market Size by Geographic Region (2021-2026)
4.1.1 Global Recombinant Mouse Oncostatin M (OSM) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Recombinant Mouse Oncostatin M (OSM) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Recombinant Mouse Oncostatin M (OSM) Market Size by Country/Region (2021-2026)
4.2.1 Global Recombinant Mouse Oncostatin M (OSM) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Recombinant Mouse Oncostatin M (OSM) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Recombinant Mouse Oncostatin M (OSM) Sales Growth
4.4 APAC Recombinant Mouse Oncostatin M (OSM) Sales Growth
4.5 Europe Recombinant Mouse Oncostatin M (OSM) Sales Growth
4.6 Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Sales Growth
5 AMERICAS
5.1 Americas Recombinant Mouse Oncostatin M (OSM) Sales by Country
5.1.1 Americas Recombinant Mouse Oncostatin M (OSM) Sales by Country (2021-2026)
5.1.2 Americas Recombinant Mouse Oncostatin M (OSM) Revenue by Country (2021-2026)
5.2 Americas Recombinant Mouse Oncostatin M (OSM) Sales by Type (2021-2026)
5.3 Americas Recombinant Mouse Oncostatin M (OSM) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Mouse Oncostatin M (OSM) Sales by Region
6.1.1 APAC Recombinant Mouse Oncostatin M (OSM) Sales by Region (2021-2026)
6.1.2 APAC Recombinant Mouse Oncostatin M (OSM) Revenue by Region (2021-2026)
6.2 APAC Recombinant Mouse Oncostatin M (OSM) Sales by Type (2021-2026)
6.3 APAC Recombinant Mouse Oncostatin M (OSM) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Recombinant Mouse Oncostatin M (OSM) by Country
7.1.1 Europe Recombinant Mouse Oncostatin M (OSM) Sales by Country (2021-2026)
7.1.2 Europe Recombinant Mouse Oncostatin M (OSM) Revenue by Country (2021-2026)
7.2 Europe Recombinant Mouse Oncostatin M (OSM) Sales by Type (2021-2026)
7.3 Europe Recombinant Mouse Oncostatin M (OSM) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant Mouse Oncostatin M (OSM) by Country
8.1.1 Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Revenue by Country (2021-2026)
8.2 Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Sales by Type (2021-2026)
8.3 Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Mouse Oncostatin M (OSM)
10.3 Manufacturing Process Analysis of Recombinant Mouse Oncostatin M (OSM)
10.4 Industry Chain Structure of Recombinant Mouse Oncostatin M (OSM)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant Mouse Oncostatin M (OSM) Distributors
11.3 Recombinant Mouse Oncostatin M (OSM) Customer
12 WORLD FORECAST REVIEW FOR RECOMBINANT MOUSE ONCOSTATIN M (OSM) BY GEOGRAPHIC REGION
12.1 Global Recombinant Mouse Oncostatin M (OSM) Market Size Forecast by Region
12.1.1 Global Recombinant Mouse Oncostatin M (OSM) Forecast by Region (2027-2032)
12.1.2 Global Recombinant Mouse Oncostatin M (OSM) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Recombinant Mouse Oncostatin M (OSM) Forecast by Type (2027-2032)
12.7 Global Recombinant Mouse Oncostatin M (OSM) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Thermo Fisher Scientific Inc.
13.1.1 Thermo Fisher Scientific Inc. Company Information
13.1.2 Thermo Fisher Scientific Inc. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.1.3 Thermo Fisher Scientific Inc. Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Thermo Fisher Scientific Inc. Main Business Overview
13.1.5 Thermo Fisher Scientific Inc. Latest Developments
13.2 Bio-Techne
13.2.1 Bio-Techne Company Information
13.2.2 Bio-Techne Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.2.3 Bio-Techne Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Bio-Techne Main Business Overview
13.2.5 Bio-Techne Latest Developments
13.3 Scientists Helping Scientists
13.3.1 Scientists Helping Scientists Company Information
13.3.2 Scientists Helping Scientists Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.3.3 Scientists Helping Scientists Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Scientists Helping Scientists Main Business Overview
13.3.5 Scientists Helping Scientists Latest Developments
13.4 Abcam Limited
13.4.1 Abcam Limited Company Information
13.4.2 Abcam Limited Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.4.3 Abcam Limited Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Abcam Limited Main Business Overview
13.4.5 Abcam Limited Latest Developments
13.5 FUJIFILM Irvine Scientific
13.5.1 FUJIFILM Irvine Scientific Company Information
13.5.2 FUJIFILM Irvine Scientific Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.5.3 FUJIFILM Irvine Scientific Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 FUJIFILM Irvine Scientific Main Business Overview
13.5.5 FUJIFILM Irvine Scientific Latest Developments
13.6 BD Biosciences
13.6.1 BD Biosciences Company Information
13.6.2 BD Biosciences Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.6.3 BD Biosciences Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 BD Biosciences Main Business Overview
13.6.5 BD Biosciences Latest Developments
13.7 Bio-Rad Laboratories, Inc.
13.7.1 Bio-Rad Laboratories, Inc. Company Information
13.7.2 Bio-Rad Laboratories, Inc. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.7.3 Bio-Rad Laboratories, Inc. Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Bio-Rad Laboratories, Inc. Main Business Overview
13.7.5 Bio-Rad Laboratories, Inc. Latest Developments
13.8 BPS Bioscience, Inc.
13.8.1 BPS Bioscience, Inc. Company Information
13.8.2 BPS Bioscience, Inc. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.8.3 BPS Bioscience, Inc. Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 BPS Bioscience, Inc. Main Business Overview
13.8.5 BPS Bioscience, Inc. Latest Developments
13.9 Elabscience
13.9.1 Elabscience Company Information
13.9.2 Elabscience Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.9.3 Elabscience Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Elabscience Main Business Overview
13.9.5 Elabscience Latest Developments
13.10 Yisheng Biotechnology (Shanghai) Co., Ltd.
13.10.1 Yisheng Biotechnology (Shanghai) Co., Ltd. Company Information
13.10.2 Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.10.3 Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Yisheng Biotechnology (Shanghai) Co., Ltd. Main Business Overview
13.10.5 Yisheng Biotechnology (Shanghai) Co., Ltd. Latest Developments
13.11 ENZO
13.11.1 ENZO Company Information
13.11.2 ENZO Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.11.3 ENZO Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 ENZO Main Business Overview
13.11.5 ENZO Latest Developments
13.12 Beijing Biocreative Technology Co., Ltd.
13.12.1 Beijing Biocreative Technology Co., Ltd. Company Information
13.12.2 Beijing Biocreative Technology Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.12.3 Beijing Biocreative Technology Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Beijing Biocreative Technology Co., Ltd. Main Business Overview
13.12.5 Beijing Biocreative Technology Co., Ltd. Latest Developments
13.13 Shanghai Yaji Biotechnology Co., Ltd.
13.13.1 Shanghai Yaji Biotechnology Co., Ltd. Company Information
13.13.2 Shanghai Yaji Biotechnology Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.13.3 Shanghai Yaji Biotechnology Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Shanghai Yaji Biotechnology Co., Ltd. Main Business Overview
13.13.5 Shanghai Yaji Biotechnology Co., Ltd. Latest Developments
13.14 Cellverse Co., Ltd.
13.14.1 Cellverse Co., Ltd. Company Information
13.14.2 Cellverse Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.14.3 Cellverse Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Cellverse Co., Ltd. Main Business Overview
13.14.5 Cellverse Co., Ltd. Latest Developments
13.15 Dalian Meilun Biotech Co., Ltd.
13.15.1 Dalian Meilun Biotech Co., Ltd. Company Information
13.15.2 Dalian Meilun Biotech Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.15.3 Dalian Meilun Biotech Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Dalian Meilun Biotech Co., Ltd. Main Business Overview
13.15.5 Dalian Meilun Biotech Co., Ltd. Latest Developments
13.16 Sino Biological,Inc.
13.16.1 Sino Biological,Inc. Company Information
13.16.2 Sino Biological,Inc. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.16.3 Sino Biological,Inc. Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Sino Biological,Inc. Main Business Overview
13.16.5 Sino Biological,Inc. Latest Developments
13.17 Prospec-Tany Technogene Ltd
13.17.1 Prospec-Tany Technogene Ltd Company Information
13.17.2 Prospec-Tany Technogene Ltd Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
13.17.3 Prospec-Tany Technogene Ltd Recombinant Mouse Oncostatin M (OSM) Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Prospec-Tany Technogene Ltd Main Business Overview
13.17.5 Prospec-Tany Technogene Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Recombinant Mouse Oncostatin M (OSM) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Recombinant Mouse Oncostatin M (OSM) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Purity?95%
Table 4. Major Players of Purity ?95%
Table 5. Global Recombinant Mouse Oncostatin M (OSM) Sales by Type (2021-2026) & (K Units)
Table 6. Global Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Type (2021-2026)
Table 7. Global Recombinant Mouse Oncostatin M (OSM) Revenue by Type (2021-2026) & ($ million)
Table 8. Global Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Type (2021-2026)
Table 9. Global Recombinant Mouse Oncostatin M (OSM) Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Recombinant Mouse Oncostatin M (OSM) Sale by Application (2021-2026) & (K Units)
Table 11. Global Recombinant Mouse Oncostatin M (OSM) Sale Market Share by Application (2021-2026)
Table 12. Global Recombinant Mouse Oncostatin M (OSM) Revenue by Application (2021-2026) & ($ million)
Table 13. Global Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Application (2021-2026)
Table 14. Global Recombinant Mouse Oncostatin M (OSM) Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Recombinant Mouse Oncostatin M (OSM) Sales by Company (2021-2026) & (K Units)
Table 16. Global Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Company (2021-2026)
Table 17. Global Recombinant Mouse Oncostatin M (OSM) Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Company (2021-2026)
Table 19. Global Recombinant Mouse Oncostatin M (OSM) Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Recombinant Mouse Oncostatin M (OSM) Producing Area Distribution and Sales Area
Table 21. Players Recombinant Mouse Oncostatin M (OSM) Products Offered
Table 22. Recombinant Mouse Oncostatin M (OSM) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Recombinant Mouse Oncostatin M (OSM) Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Recombinant Mouse Oncostatin M (OSM) Sales Market Share Geographic Region (2021-2026)
Table 27. Global Recombinant Mouse Oncostatin M (OSM) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Recombinant Mouse Oncostatin M (OSM) Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Country/Region (2021-2026)
Table 31. Global Recombinant Mouse Oncostatin M (OSM) Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Recombinant Mouse Oncostatin M (OSM) Sales by Country (2021-2026) & (K Units)
Table 34. Americas Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Country (2021-2026)
Table 35. Americas Recombinant Mouse Oncostatin M (OSM) Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Recombinant Mouse Oncostatin M (OSM) Sales by Type (2021-2026) & (K Units)
Table 37. Americas Recombinant Mouse Oncostatin M (OSM) Sales by Application (2021-2026) & (K Units)
Table 38. APAC Recombinant Mouse Oncostatin M (OSM) Sales by Region (2021-2026) & (K Units)
Table 39. APAC Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Region (2021-2026)
Table 40. APAC Recombinant Mouse Oncostatin M (OSM) Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Recombinant Mouse Oncostatin M (OSM) Sales by Type (2021-2026) & (K Units)
Table 42. APAC Recombinant Mouse Oncostatin M (OSM) Sales by Application (2021-2026) & (K Units)
Table 43. Europe Recombinant Mouse Oncostatin M (OSM) Sales by Country (2021-2026) & (K Units)
Table 44. Europe Recombinant Mouse Oncostatin M (OSM) Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Recombinant Mouse Oncostatin M (OSM) Sales by Type (2021-2026) & (K Units)
Table 46. Europe Recombinant Mouse Oncostatin M (OSM) Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Recombinant Mouse Oncostatin M (OSM)
Table 52. Key Market Challenges & Risks of Recombinant Mouse Oncostatin M (OSM)
Table 53. Key Industry Trends of Recombinant Mouse Oncostatin M (OSM)
Table 54. Recombinant Mouse Oncostatin M (OSM) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Recombinant Mouse Oncostatin M (OSM) Distributors List
Table 57. Recombinant Mouse Oncostatin M (OSM) Customer List
Table 58. Global Recombinant Mouse Oncostatin M (OSM) Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Recombinant Mouse Oncostatin M (OSM) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Recombinant Mouse Oncostatin M (OSM) Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Recombinant Mouse Oncostatin M (OSM) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Recombinant Mouse Oncostatin M (OSM) Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Recombinant Mouse Oncostatin M (OSM) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Recombinant Mouse Oncostatin M (OSM) Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Recombinant Mouse Oncostatin M (OSM) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Recombinant Mouse Oncostatin M (OSM) Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Recombinant Mouse Oncostatin M (OSM) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Recombinant Mouse Oncostatin M (OSM) Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Recombinant Mouse Oncostatin M (OSM) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Thermo Fisher Scientific Inc. Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 73. Thermo Fisher Scientific Inc. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 74. Thermo Fisher Scientific Inc. Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Thermo Fisher Scientific Inc. Main Business
Table 76. Thermo Fisher Scientific Inc. Latest Developments
Table 77. Bio-Techne Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 78. Bio-Techne Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 79. Bio-Techne Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Bio-Techne Main Business
Table 81. Bio-Techne Latest Developments
Table 82. Scientists Helping Scientists Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 83. Scientists Helping Scientists Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 84. Scientists Helping Scientists Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Scientists Helping Scientists Main Business
Table 86. Scientists Helping Scientists Latest Developments
Table 87. Abcam Limited Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 88. Abcam Limited Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 89. Abcam Limited Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Abcam Limited Main Business
Table 91. Abcam Limited Latest Developments
Table 92. FUJIFILM Irvine Scientific Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 93. FUJIFILM Irvine Scientific Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 94. FUJIFILM Irvine Scientific Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. FUJIFILM Irvine Scientific Main Business
Table 96. FUJIFILM Irvine Scientific Latest Developments
Table 97. BD Biosciences Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 98. BD Biosciences Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 99. BD Biosciences Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. BD Biosciences Main Business
Table 101. BD Biosciences Latest Developments
Table 102. Bio-Rad Laboratories, Inc. Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 103. Bio-Rad Laboratories, Inc. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 104. Bio-Rad Laboratories, Inc. Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Bio-Rad Laboratories, Inc. Main Business
Table 106. Bio-Rad Laboratories, Inc. Latest Developments
Table 107. BPS Bioscience, Inc. Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 108. BPS Bioscience, Inc. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 109. BPS Bioscience, Inc. Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. BPS Bioscience, Inc. Main Business
Table 111. BPS Bioscience, Inc. Latest Developments
Table 112. Elabscience Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 113. Elabscience Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 114. Elabscience Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Elabscience Main Business
Table 116. Elabscience Latest Developments
Table 117. Yisheng Biotechnology (Shanghai) Co., Ltd. Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 118. Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 119. Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Yisheng Biotechnology (Shanghai) Co., Ltd. Main Business
Table 121. Yisheng Biotechnology (Shanghai) Co., Ltd. Latest Developments
Table 122. ENZO Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 123. ENZO Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 124. ENZO Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. ENZO Main Business
Table 126. ENZO Latest Developments
Table 127. Beijing Biocreative Technology Co., Ltd. Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 128. Beijing Biocreative Technology Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 129. Beijing Biocreative Technology Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Beijing Biocreative Technology Co., Ltd. Main Business
Table 131. Beijing Biocreative Technology Co., Ltd. Latest Developments
Table 132. Shanghai Yaji Biotechnology Co., Ltd. Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 133. Shanghai Yaji Biotechnology Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 134. Shanghai Yaji Biotechnology Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Shanghai Yaji Biotechnology Co., Ltd. Main Business
Table 136. Shanghai Yaji Biotechnology Co., Ltd. Latest Developments
Table 137. Cellverse Co., Ltd. Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 138. Cellverse Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 139. Cellverse Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Cellverse Co., Ltd. Main Business
Table 141. Cellverse Co., Ltd. Latest Developments
Table 142. Dalian Meilun Biotech Co., Ltd. Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 143. Dalian Meilun Biotech Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 144. Dalian Meilun Biotech Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Dalian Meilun Biotech Co., Ltd. Main Business
Table 146. Dalian Meilun Biotech Co., Ltd. Latest Developments
Table 147. Sino Biological,Inc. Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 148. Sino Biological,Inc. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 149. Sino Biological,Inc. Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Sino Biological,Inc. Main Business
Table 151. Sino Biological,Inc. Latest Developments
Table 152. Prospec-Tany Technogene Ltd Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 153. Prospec-Tany Technogene Ltd Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 154. Prospec-Tany Technogene Ltd Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Prospec-Tany Technogene Ltd Main Business
Table 156. Prospec-Tany Technogene Ltd Latest Developments
Table 1. Recombinant Mouse Oncostatin M (OSM) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Recombinant Mouse Oncostatin M (OSM) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Purity?95%
Table 4. Major Players of Purity ?95%
Table 5. Global Recombinant Mouse Oncostatin M (OSM) Sales by Type (2021-2026) & (K Units)
Table 6. Global Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Type (2021-2026)
Table 7. Global Recombinant Mouse Oncostatin M (OSM) Revenue by Type (2021-2026) & ($ million)
Table 8. Global Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Type (2021-2026)
Table 9. Global Recombinant Mouse Oncostatin M (OSM) Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Recombinant Mouse Oncostatin M (OSM) Sale by Application (2021-2026) & (K Units)
Table 11. Global Recombinant Mouse Oncostatin M (OSM) Sale Market Share by Application (2021-2026)
Table 12. Global Recombinant Mouse Oncostatin M (OSM) Revenue by Application (2021-2026) & ($ million)
Table 13. Global Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Application (2021-2026)
Table 14. Global Recombinant Mouse Oncostatin M (OSM) Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Recombinant Mouse Oncostatin M (OSM) Sales by Company (2021-2026) & (K Units)
Table 16. Global Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Company (2021-2026)
Table 17. Global Recombinant Mouse Oncostatin M (OSM) Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Company (2021-2026)
Table 19. Global Recombinant Mouse Oncostatin M (OSM) Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Recombinant Mouse Oncostatin M (OSM) Producing Area Distribution and Sales Area
Table 21. Players Recombinant Mouse Oncostatin M (OSM) Products Offered
Table 22. Recombinant Mouse Oncostatin M (OSM) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Recombinant Mouse Oncostatin M (OSM) Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Recombinant Mouse Oncostatin M (OSM) Sales Market Share Geographic Region (2021-2026)
Table 27. Global Recombinant Mouse Oncostatin M (OSM) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Recombinant Mouse Oncostatin M (OSM) Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Country/Region (2021-2026)
Table 31. Global Recombinant Mouse Oncostatin M (OSM) Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Recombinant Mouse Oncostatin M (OSM) Sales by Country (2021-2026) & (K Units)
Table 34. Americas Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Country (2021-2026)
Table 35. Americas Recombinant Mouse Oncostatin M (OSM) Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Recombinant Mouse Oncostatin M (OSM) Sales by Type (2021-2026) & (K Units)
Table 37. Americas Recombinant Mouse Oncostatin M (OSM) Sales by Application (2021-2026) & (K Units)
Table 38. APAC Recombinant Mouse Oncostatin M (OSM) Sales by Region (2021-2026) & (K Units)
Table 39. APAC Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Region (2021-2026)
Table 40. APAC Recombinant Mouse Oncostatin M (OSM) Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Recombinant Mouse Oncostatin M (OSM) Sales by Type (2021-2026) & (K Units)
Table 42. APAC Recombinant Mouse Oncostatin M (OSM) Sales by Application (2021-2026) & (K Units)
Table 43. Europe Recombinant Mouse Oncostatin M (OSM) Sales by Country (2021-2026) & (K Units)
Table 44. Europe Recombinant Mouse Oncostatin M (OSM) Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Recombinant Mouse Oncostatin M (OSM) Sales by Type (2021-2026) & (K Units)
Table 46. Europe Recombinant Mouse Oncostatin M (OSM) Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Recombinant Mouse Oncostatin M (OSM)
Table 52. Key Market Challenges & Risks of Recombinant Mouse Oncostatin M (OSM)
Table 53. Key Industry Trends of Recombinant Mouse Oncostatin M (OSM)
Table 54. Recombinant Mouse Oncostatin M (OSM) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Recombinant Mouse Oncostatin M (OSM) Distributors List
Table 57. Recombinant Mouse Oncostatin M (OSM) Customer List
Table 58. Global Recombinant Mouse Oncostatin M (OSM) Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Recombinant Mouse Oncostatin M (OSM) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Recombinant Mouse Oncostatin M (OSM) Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Recombinant Mouse Oncostatin M (OSM) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Recombinant Mouse Oncostatin M (OSM) Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Recombinant Mouse Oncostatin M (OSM) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Recombinant Mouse Oncostatin M (OSM) Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Recombinant Mouse Oncostatin M (OSM) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Recombinant Mouse Oncostatin M (OSM) Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Recombinant Mouse Oncostatin M (OSM) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Recombinant Mouse Oncostatin M (OSM) Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Recombinant Mouse Oncostatin M (OSM) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Thermo Fisher Scientific Inc. Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 73. Thermo Fisher Scientific Inc. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 74. Thermo Fisher Scientific Inc. Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Thermo Fisher Scientific Inc. Main Business
Table 76. Thermo Fisher Scientific Inc. Latest Developments
Table 77. Bio-Techne Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 78. Bio-Techne Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 79. Bio-Techne Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Bio-Techne Main Business
Table 81. Bio-Techne Latest Developments
Table 82. Scientists Helping Scientists Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 83. Scientists Helping Scientists Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 84. Scientists Helping Scientists Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Scientists Helping Scientists Main Business
Table 86. Scientists Helping Scientists Latest Developments
Table 87. Abcam Limited Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 88. Abcam Limited Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 89. Abcam Limited Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Abcam Limited Main Business
Table 91. Abcam Limited Latest Developments
Table 92. FUJIFILM Irvine Scientific Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 93. FUJIFILM Irvine Scientific Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 94. FUJIFILM Irvine Scientific Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. FUJIFILM Irvine Scientific Main Business
Table 96. FUJIFILM Irvine Scientific Latest Developments
Table 97. BD Biosciences Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 98. BD Biosciences Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 99. BD Biosciences Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. BD Biosciences Main Business
Table 101. BD Biosciences Latest Developments
Table 102. Bio-Rad Laboratories, Inc. Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 103. Bio-Rad Laboratories, Inc. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 104. Bio-Rad Laboratories, Inc. Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Bio-Rad Laboratories, Inc. Main Business
Table 106. Bio-Rad Laboratories, Inc. Latest Developments
Table 107. BPS Bioscience, Inc. Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 108. BPS Bioscience, Inc. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 109. BPS Bioscience, Inc. Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. BPS Bioscience, Inc. Main Business
Table 111. BPS Bioscience, Inc. Latest Developments
Table 112. Elabscience Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 113. Elabscience Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 114. Elabscience Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Elabscience Main Business
Table 116. Elabscience Latest Developments
Table 117. Yisheng Biotechnology (Shanghai) Co., Ltd. Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 118. Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 119. Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Yisheng Biotechnology (Shanghai) Co., Ltd. Main Business
Table 121. Yisheng Biotechnology (Shanghai) Co., Ltd. Latest Developments
Table 122. ENZO Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 123. ENZO Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 124. ENZO Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. ENZO Main Business
Table 126. ENZO Latest Developments
Table 127. Beijing Biocreative Technology Co., Ltd. Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 128. Beijing Biocreative Technology Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 129. Beijing Biocreative Technology Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Beijing Biocreative Technology Co., Ltd. Main Business
Table 131. Beijing Biocreative Technology Co., Ltd. Latest Developments
Table 132. Shanghai Yaji Biotechnology Co., Ltd. Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 133. Shanghai Yaji Biotechnology Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 134. Shanghai Yaji Biotechnology Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Shanghai Yaji Biotechnology Co., Ltd. Main Business
Table 136. Shanghai Yaji Biotechnology Co., Ltd. Latest Developments
Table 137. Cellverse Co., Ltd. Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 138. Cellverse Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 139. Cellverse Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Cellverse Co., Ltd. Main Business
Table 141. Cellverse Co., Ltd. Latest Developments
Table 142. Dalian Meilun Biotech Co., Ltd. Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 143. Dalian Meilun Biotech Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 144. Dalian Meilun Biotech Co., Ltd. Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Dalian Meilun Biotech Co., Ltd. Main Business
Table 146. Dalian Meilun Biotech Co., Ltd. Latest Developments
Table 147. Sino Biological,Inc. Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 148. Sino Biological,Inc. Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 149. Sino Biological,Inc. Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Sino Biological,Inc. Main Business
Table 151. Sino Biological,Inc. Latest Developments
Table 152. Prospec-Tany Technogene Ltd Basic Information, Recombinant Mouse Oncostatin M (OSM) Manufacturing Base, Sales Area and Its Competitors
Table 153. Prospec-Tany Technogene Ltd Recombinant Mouse Oncostatin M (OSM) Product Portfolios and Specifications
Table 154. Prospec-Tany Technogene Ltd Recombinant Mouse Oncostatin M (OSM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Prospec-Tany Technogene Ltd Main Business
Table 156. Prospec-Tany Technogene Ltd Latest Developments
LIST OF FIGURES
Figure 1. Picture of Recombinant Mouse Oncostatin M (OSM)
Figure 2. Recombinant Mouse Oncostatin M (OSM) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Mouse Oncostatin M (OSM) Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Recombinant Mouse Oncostatin M (OSM) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Recombinant Mouse Oncostatin M (OSM) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Country/Region (2025)
Figure 10. Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Purity?95%
Figure 12. Product Picture of Purity ?95%
Figure 13. Global Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Type in 2026
Figure 14. Global Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Type (2021-2026)
Figure 15. Recombinant Mouse Oncostatin M (OSM) Consumed in University
Figure 16. Global Recombinant Mouse Oncostatin M (OSM) Market: University (2021-2026) & (K Units)
Figure 17. Recombinant Mouse Oncostatin M (OSM) Consumed in Research Center
Figure 18. Global Recombinant Mouse Oncostatin M (OSM) Market: Research Center (2021-2026) & (K Units)
Figure 19. Global Recombinant Mouse Oncostatin M (OSM) Sale Market Share by Application (2025)
Figure 20. Global Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Application in 2026
Figure 21. Recombinant Mouse Oncostatin M (OSM) Sales by Company in 2026 (K Units)
Figure 22. Global Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Company in 2026
Figure 23. Recombinant Mouse Oncostatin M (OSM) Revenue by Company in 2026 ($ millions)
Figure 24. Global Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Company in 2026
Figure 25. Global Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Recombinant Mouse Oncostatin M (OSM) Sales 2021-2026 (K Units)
Figure 28. Americas Recombinant Mouse Oncostatin M (OSM) Revenue 2021-2026 ($ millions)
Figure 29. APAC Recombinant Mouse Oncostatin M (OSM) Sales 2021-2026 (K Units)
Figure 30. APAC Recombinant Mouse Oncostatin M (OSM) Revenue 2021-2026 ($ millions)
Figure 31. Europe Recombinant Mouse Oncostatin M (OSM) Sales 2021-2026 (K Units)
Figure 32. Europe Recombinant Mouse Oncostatin M (OSM) Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Revenue 2021-2026 ($ millions)
Figure 35. Americas Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Country in 2026
Figure 36. Americas Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Country (2021-2026)
Figure 37. Americas Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Type (2021-2026)
Figure 38. Americas Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Application (2021-2026)
Figure 39. United States Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Region in 2026
Figure 44. APAC Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Region (2021-2026)
Figure 45. APAC Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Type (2021-2026)
Figure 46. APAC Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Application (2021-2026)
Figure 47. China Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 51. India Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Country in 2026
Figure 55. Europe Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Country (2021-2026)
Figure 56. Europe Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Type (2021-2026)
Figure 57. Europe Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Application (2021-2026)
Figure 58. Germany Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 59. France Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Application (2021-2026)
Figure 66. Egypt Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Recombinant Mouse Oncostatin M (OSM) in 2026
Figure 72. Manufacturing Process Analysis of Recombinant Mouse Oncostatin M (OSM)
Figure 73. Industry Chain Structure of Recombinant Mouse Oncostatin M (OSM)
Figure 74. Channels of Distribution
Figure 75. Global Recombinant Mouse Oncostatin M (OSM) Sales Market Forecast by Region (2027-2032)
Figure 76. Global Recombinant Mouse Oncostatin M (OSM) Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Recombinant Mouse Oncostatin M (OSM) Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Recombinant Mouse Oncostatin M (OSM) Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Recombinant Mouse Oncostatin M (OSM) Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Recombinant Mouse Oncostatin M (OSM) Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Recombinant Mouse Oncostatin M (OSM)
Figure 2. Recombinant Mouse Oncostatin M (OSM) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Mouse Oncostatin M (OSM) Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Recombinant Mouse Oncostatin M (OSM) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Recombinant Mouse Oncostatin M (OSM) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Country/Region (2025)
Figure 10. Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Purity?95%
Figure 12. Product Picture of Purity ?95%
Figure 13. Global Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Type in 2026
Figure 14. Global Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Type (2021-2026)
Figure 15. Recombinant Mouse Oncostatin M (OSM) Consumed in University
Figure 16. Global Recombinant Mouse Oncostatin M (OSM) Market: University (2021-2026) & (K Units)
Figure 17. Recombinant Mouse Oncostatin M (OSM) Consumed in Research Center
Figure 18. Global Recombinant Mouse Oncostatin M (OSM) Market: Research Center (2021-2026) & (K Units)
Figure 19. Global Recombinant Mouse Oncostatin M (OSM) Sale Market Share by Application (2025)
Figure 20. Global Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Application in 2026
Figure 21. Recombinant Mouse Oncostatin M (OSM) Sales by Company in 2026 (K Units)
Figure 22. Global Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Company in 2026
Figure 23. Recombinant Mouse Oncostatin M (OSM) Revenue by Company in 2026 ($ millions)
Figure 24. Global Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Company in 2026
Figure 25. Global Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Recombinant Mouse Oncostatin M (OSM) Sales 2021-2026 (K Units)
Figure 28. Americas Recombinant Mouse Oncostatin M (OSM) Revenue 2021-2026 ($ millions)
Figure 29. APAC Recombinant Mouse Oncostatin M (OSM) Sales 2021-2026 (K Units)
Figure 30. APAC Recombinant Mouse Oncostatin M (OSM) Revenue 2021-2026 ($ millions)
Figure 31. Europe Recombinant Mouse Oncostatin M (OSM) Sales 2021-2026 (K Units)
Figure 32. Europe Recombinant Mouse Oncostatin M (OSM) Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Revenue 2021-2026 ($ millions)
Figure 35. Americas Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Country in 2026
Figure 36. Americas Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Country (2021-2026)
Figure 37. Americas Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Type (2021-2026)
Figure 38. Americas Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Application (2021-2026)
Figure 39. United States Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Region in 2026
Figure 44. APAC Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Region (2021-2026)
Figure 45. APAC Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Type (2021-2026)
Figure 46. APAC Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Application (2021-2026)
Figure 47. China Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 51. India Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Country in 2026
Figure 55. Europe Recombinant Mouse Oncostatin M (OSM) Revenue Market Share by Country (2021-2026)
Figure 56. Europe Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Type (2021-2026)
Figure 57. Europe Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Application (2021-2026)
Figure 58. Germany Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 59. France Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Recombinant Mouse Oncostatin M (OSM) Sales Market Share by Application (2021-2026)
Figure 66. Egypt Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Recombinant Mouse Oncostatin M (OSM) Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Recombinant Mouse Oncostatin M (OSM) in 2026
Figure 72. Manufacturing Process Analysis of Recombinant Mouse Oncostatin M (OSM)
Figure 73. Industry Chain Structure of Recombinant Mouse Oncostatin M (OSM)
Figure 74. Channels of Distribution
Figure 75. Global Recombinant Mouse Oncostatin M (OSM) Sales Market Forecast by Region (2027-2032)
Figure 76. Global Recombinant Mouse Oncostatin M (OSM) Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Recombinant Mouse Oncostatin M (OSM) Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Recombinant Mouse Oncostatin M (OSM) Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Recombinant Mouse Oncostatin M (OSM) Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Recombinant Mouse Oncostatin M (OSM) Revenue Market Share Forecast by Application (2027-2032)
